StartUp Health

Founded in 2011, StartUp Health is dedicated to improving global health through collaboration with entrepreneurs. It invests in 'Health Transformers' across six continents, focusing on various health moonshots such as Access to Care, Cure Disease, and Mental Health. With over 330 companies in its portfolio, it's backed by prominent investors.

Joshua Cherry-Seto

Partner and CFO

Katya Hancock

Partner and Chief Impact Officer

Steven Krein JD

Managing Partner

Priya Reddy

Associate

Unity Stoakes

President

Past deals in Medical Devices

MoodMD

Venture Round in 2022
Founded in 2019, MoodMD offers a comprehensive online program for improving mood. It combines self-driven tools, neurohormonal assessments, and specialized talk therapy to address factors influencing mood disorders like stress, anxiety, and depression.

LumosTech

Venture Round in 2022
LumosTech, Inc. is a San Francisco-based company that specializes in developing and selling padded light-therapy eye masks designed to address sleep disorders. Founded in 2014, LumosTech offers a non-pharmaceutical solution for individuals such as travelers, shift workers, teenagers, and the elderly, who are seeking to enhance their sleep quality naturally. The company's innovative product, rooted in scientific research from Stanford University, utilizes low-intensity light flashes to help regulate the body's internal clock, enabling users to restore their sleep cycles without the side effects associated with traditional medications. By providing a natural remedy for sleep issues, LumosTech aims to help users wake up refreshed and ready to perform at their best. The products are primarily sold online, making them accessible to a wide audience.

Spotlight Consultations Limited (dba Spotlight-AQ)

Venture Round in 2022
Spotlight-AQ is a user-friendly, pragmatic tool that helps with patient engagement and sets the scene for the consultation. It was founded in 2020.

Difinity Solutions

Pre Seed Round in 2022
Difinity Solutions specializes in developing and commercializing innovative medication delivery systems for critical situations such as opioid overdose and anaphylaxis. They offer a range of services including medical, engineering, regulatory, and technology support to optimize patient outcomes and enhance emergency care.

Scan.com

Seed Round in 2022
Scan.com is a diagnostic imaging platform serving the United Kingdom and United States markets. It operates as a multi-sided platform that links outpatient diagnostic centers on the supply side with outpatient clinicians on the demand side, enabling clinicians to order imaging for patients. The platform aims to improve access to medical imaging by providing EMR-integrated workflow solutions that are free to use for referring clinicians, and it expands through local metro networks of imaging centers and referring clinicians.

Modern Ritual

Venture Round in 2022
Modern Ritual operates a tele-dermatology platform designed to enhance early detection of skin cancer. It offers fast imaging, e-consultation services, and teledermatology assessments, expanding access to dermatological care and enabling healthcare providers to promptly assess and triage common skin conditions.

De Oro Devices

Seed Round in 2022
De Oro Devices is a device that re-establishing the connection between the brain and the body. Attach a NexStride to cane, walker, and walking poles that help to reduce the duration and frequency of freezing episodes.

Quickr Health

Angel Round in 2022
Quickr Health is a developer of a MedTech platform aimed at enhancing the efficiency of direct primary care providers. Its innovative platform combines features of electronic health records and customer relationship management, streamlining various processes such as appointment scheduling, health charts, and messaging services. By offering these integrated tools, Quickr Health empowers both healthcare providers and patients to manage and control their health data effectively, ultimately saving time and improving the quality of care. This focus on user-friendly solutions positions Quickr Health as a valuable resource in the healthcare technology landscape.

Lazzaro Medical

Grant in 2022
Lazzaro Medical develops minimally invasive medical devices to treat tracheobronchomalacia (TBM), a condition affecting millions worldwide. Their platform includes a robotic tracheal scaffold system for airway support, diagnostic tools for rapid disease identification, surgical training programs, and patented endotracheal tubes, enabling healthcare providers to deliver safer, more efficient treatments with reduced operating and recovery times.

BrainScanology

Venture Round in 2022
BrainScanology Inc. specializes in advanced brain scanning analysis technology that aims to enhance the diagnostic capabilities of medical professionals, particularly in the fields of psychiatry and radiology. The company’s proprietary tool, ShapeGenie, significantly improves shape analysis at the cellular level without relying on traditional area or volume measurements. This innovative approach allows for more accurate diagnostics, addressing common challenges faced by radiologists due to mental fatigue. Additionally, BrainScanology's technology enables the early detection and monitoring of psychiatric disorders, such as dementia and schizophrenia, by providing annual assessments of disease progression. This reduces diagnostic uncertainty and facilitates the development of machine learning models for improved disease subtype identification. Overall, BrainScanology is committed to revolutionizing diagnostic processes in healthcare through its cutting-edge technology.

TYDEi

Venture Round in 2022
TYDEi Health is a company that specializes in automating transactions within the healthcare sector, specifically from the point of surgery to inventory replenishment. Their platform focuses on vendor relationship management, allowing healthcare organizations to streamline processes and improve efficiency. TYDEi Health's services include digital authentication of product safety and compliance, as well as the creation of digital audit trails and automated purchase orders. The company also offers real-time data dashboards to manage medical device utilization and pricing effectively. By employing smart contracts, TYDEi Health enhances revenue maximization and cost reduction for healthcare firms through automated rebate calculations, price checks, and order processing.

Wide Awake VR

Seed Round in 2021
Wide Awake VR is a company that specializes in providing an immersive media content platform using virtual reality technology to enhance the surgical experience for patients. By offering customized VR content during medical procedures, the company aims to help alleviate anxiety and pain, allowing patients to undergo minor surgeries with local anesthesia rather than general anesthesia. This approach not only improves patient comfort but also enhances the efficiency and safety of surgical practices within medical offices. Through its innovative use of virtual reality, Wide Awake VR seeks to transform how patients experience surgical interventions.

Everyplace Labs

Seed Round in 2021
Everyplace Labs develops automated point-of-care testing solutions. Their self-service kiosk enables patient-initiated or staff-assisted urine diagnostics, reducing bottlenecks and improving efficiency in acute care settings.

InSilicoTrials

Seed Round in 2020
Founded in 2018 by experts in life science, cybersecurity, and digital innovation, InSilicoTrials accelerates drug and medical device development through its cloud-based platform. It offers state-of-the-art simulation tools that reduce costs and time, enabling cheaper treatments, faster market access for innovative drugs, and personalized cures.

Sana Health

Seed Round in 2020
Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

eko.ai

Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Alerje

Seed Round in 2020
Alerje, Inc. is a Detroit-based company focused on enhancing the quality of life for individuals with food allergies. Founded in 2015, Alerje has developed an innovative emergency medicine and digital oral immunotherapy management platform. Central to its offerings is an epinephrine auto-injector that conveniently fits into a smartphone case, promoting better adherence and alert management for users. The company also provides a mobile application that allows users to create personalized food allergy profiles, share these profiles with caregivers and medical professionals, and filter recipes based on allergen information. Additionally, the app includes features for scanning grocery items to identify potential allergens, thus aiding families and healthcare providers in making informed dietary choices. Alerje's platform is validated by the National Science Foundation and aims to improve emergency response and overall management of food allergies.

Virtuleap

Pre Seed Round in 2019
Virtuleap is a cognitive therapeutics company that combines neuroscience and virtual reality to enhance attention and address cognitive illnesses, disorders, and learning challenges. Its platform hosts a library of neuroscience-informed VR games designed to test and train a range of cognitive abilities, with data collected and made accessible through an enterprise platform. The company offers Enhance VR, a brain training app with gamified workouts across attention, memory, problem-solving, and other domains, and Cogniclear VR, a VR-based cognitive screening tool that uses gamified scenarios to assess a broad set of cognitive functions. The platform also integrates artificial intelligence to support immersive training and assessment for researchers and healthcare providers, enabling monitoring of cognitive function and early intervention. Virtuleap has partnered with organizations including AARP as a paid client and is collaborating with VA Health Care System and the Pacific Brain Health Center to validate its solution for attention deficits and cognitive decline.

Cala Health

Series C in 2019
Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.

MedForums

Seed Round in 2019
MedForums operates an online platform facilitating physician community engagement. Its platform enables users to crowdsource peers for discovering optimal medical education resources, practice tools, employment opportunities, and medical products.

SyncThink

Seed Round in 2019
SyncThink Inc. is a neuro-technology company based in Palo Alto, California, that specializes in eye-tracking technology for brain health analytics. Founded in 2009 by neurosurgeon Dr. Jamshid Ghajar, the company has developed the EYE-SYNC device, a non-invasive, head-mounted eye-tracking system designed to provide medical professionals with objective metrics related to visual attention and dynamic orientation. EYE-SYNC performs a rapid, 60-second assessment to identify ocular motor impairments and vestibular dysfunction, which are critical components in concussion evaluation. This technology is utilized by various university athletic departments and medical facilities, including Stanford University and Massachusetts General Hospital, for brain health assessment and recovery monitoring. SyncThink's innovations are backed by numerous partnerships with leading research institutions and have received FDA approval, making them applicable in military and athletic contexts as well as in broader applications related to attention development and brain performance. The company holds multiple patents related to its technology and analytics, further solidifying its position in the neuro-diagnostics field.

Tahmo

Seed Round in 2019
Tahmo develops smart devices for health and comfort segments of the IoT industry. Its products include temperature and humidity monitors, a smart baby thermometer, and other intelligent tools designed to enhance user experience through a free mobile app and cloud-based tracking.

Babyscripts

Corporate Round in 2019
Babyscripts is a health technology company that provides a virtual maternity care platform for prenatal and postpartum management. The platform combines a mobile education layer with gestational-age content and resources through one year postpartum, remote monitoring using connected medical devices, and a collaboration with payers to improve care coordination and reduce costs. This three-tier approach enables clinicians to manage pregnancies outside the clinic, monitor risk factors remotely, and intervene promptly when needed, while expanding access and automating routine elements of care to support better outcomes for mothers and infants.

Resility Health

Seed Round in 2018
Resility Health is a digital platform that assesses, monitors, and manages stress for individuals, families, employers, and healthcare providers. It combines stress-management techniques with biofeedback from wearable sensors and uses machine learning to create personalized training programs that continually adapt to the user. The platform supports on-the-job stress management, enhances coping skills and relationships, and mitigates the physical impacts of stress on medical conditions, with the aim of reducing chronic pain and anxiety and delivering better health outcomes at lower costs.

Welwaze Medical

Seed Round in 2018
Welwaze Medical is focused on reducing breast cancer mortality through innovative medical solutions. The company has developed a disposable breast thermometric device designed for the early detection of breast diseases, including breast cancer. This non-invasive and non-powered device allows women to monitor their breast health quickly and conveniently. In addition to the device, Welwaze Medical employs an artificial intelligence model that provides predictive and personalized recommendations aimed at enhancing women's breast wellness. This comprehensive approach not only aids researchers and medical practitioners in improving care but also assists payers in optimizing costs associated with breast disease management. The device has received regulatory clearance from the FDA, the European Union, and various health authorities worldwide.

NuEyes Technologies

Seed Round in 2018
NuEyes Technologies Inc. is a technology company that specializes in developing innovative glasses and software designed to assist individuals with visual impairments, such as macular degeneration, glaucoma, and retinitis pigmentosa. Founded in 2016 and based in Newport Beach, California, NuEyes offers smart glasses equipped with an adjustable HD magnification camera that captures images and projects them onto the back of the lenses, allowing users to see with customized magnification and brightness. The glasses feature wireless, battery-powered functionality and hands-free, voice-activated controls for ease of use. NuEyes provides two product variants, NuEyes Easy and NuEyes Pro, delivering a comprehensive solution tailored to the needs of those with vision challenges.

Zeleo

Seed Round in 2018
Zeleo is a technology company focused on healthcare integration and automation. It provides a HIPAA-compliant platform that addresses the challenges of healthcare interoperability by seamlessly connecting various software services, including medical devices and electronic medical records (EMR). The platform features a user-friendly configuration tool that simplifies the process of establishing interactions between systems, allowing users to create Application Programming Interface (API) connections without writing code. This capability enhances productivity and reduces management hours by enabling efficient collaboration across diverse software and device platforms. Zeleo's commitment to integrating technology aims to support individuals in maintaining a healthy lifestyle through improved healthcare connectivity.

Upside Health

Venture Round in 2018
Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its innovative mobile application, Ouchie. This application provides patients with targeted educational content and rewards for achieving functional milestones, fostering a supportive community for individuals managing chronic pain. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to access valuable data, improving care outcomes while minimizing additional burdens on healthcare providers. By empowering both patients and clinicians, Upside Health aims to transform the assessment and treatment of chronic pain, ultimately enhancing the quality of care and reducing healthcare costs.

PigPug Health

Seed Round in 2018
PigPug Health specializes in home-based neurofeedback therapy for ADHD and autism. They offer brain-training games that help children improve focus and learning abilities, guided by remote neurofeedback trainers.

Clusio

Seed Round in 2018
Clusio is a software company that provides a mobile application designed for clinicians and healthcare systems. The platform offers features for procedure logging and document storage, ensuring compliance with HIPAA regulations. Clinicians can use the application at no cost, while healthcare systems can integrate Clusio to enhance their offerings. This integration allows systems to track clinician competency, manage risk, and gain valuable insights from clinical data. Additionally, Clusio's software facilitates the organization of credentials and certifications, supporting clinicians throughout their professional journey from education to practice in clinical settings.

eko.ai

Pre Seed Round in 2018
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Oratel Diagnostics

Seed Round in 2018
Oratel Diagnostics, established in 2006 and based in Hammondsport, New York, specializes in developing diagnostic tools for mammalian fertility using plant pigment chemistry. The company's initial product is an ovulation detection test designed for dairy cattle, with plans to extend this technology to other livestock. Additionally, Oratel has developed saliva-based diagnostic devices that employ plant pigments to identify endometriosis and other reproductive disorders in women, aiding physicians in distinguishing pelvic pain causes and resolving fertility issues.

AzaadHealth

Seed Round in 2018
AzaadHealth is a healthcare company based in Karachi, Sindh, that specializes in creating a patient-centered health data exchange network and patient identification platform. Founded in 2016, the company provides a HIPAA-compliant online platform that facilitates secure and seamless sharing of medical information among healthcare stakeholders, including payors, providers, and patients. AzaadHealth's innovative platform enables the exchange of verifiable health data and utilizes biometric scans for patient identification, allowing healthcare providers to gain a comprehensive understanding of patients' well-being.

Omnia Salud

Seed Round in 2018
Omnia Salud specializes in migrating medical practices to fully integrated electronic health record (EHR) platforms. It offers e-health services that replace paper-based systems with digital solutions, encompassing administrative processes, electronic medical records, medications, and indications. The company's physician-centric platform caters to various specialties like mental health, assisted fertility, and gastroenterology, enabling large healthcare systems in Latin America to digitize operations and reduce costs.

Trak

Series A in 2018
Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

MirrorMe3D

Seed Round in 2018
MirrorMe3D develops physician-centered 3D imaging and printing technology for cosmetic and plastic surgery. The platform combines 3D medical imaging, augmented reality, and additive manufacturing to produce rhinoplasty and full-face models used for preoperative planning, patient consultation, and reference during procedures. It provides virtual surgical planning, remote monitoring, secure imaging asset management, and access to comprehensive patient data to support outcomes analysis, referral coordination, and treatment planning, enabling hospitals and clinics to improve patient outcomes and standard of care.

Life Recovery Systems

Seed Round in 2017
Life Recovery Systems is a medical device company based in Waldwick, New Jersey, specializing in the development and marketing of products for the emergency medical care market. The company offers the ThermoSuit system, a noninvasive device designed to reduce a patient's body temperature. This technology aims to protect patients from damage and prevent fatal outcomes related to oxygen deficiency, thereby assisting medical practitioners in effectively managing critical health conditions and emergencies.

Fruit Street

Debt Financing in 2017
Fruit Street offers a virtual diabetes prevention program. It helps participants adopt healthier lifestyles to prevent type 2 diabetes through online classes, personalized tracking of diet and activity, and integration with wireless scales for progress monitoring.

Trak

Venture Round in 2017
Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Solius

Seed Round in 2017
Solius is a company based in Bainbridge Island, Washington, founded in 2011, that specializes in manufacturing light therapy kiosks aimed at combating vitamin D deficiency. Its innovative device utilizes nano-spectrums of ultraviolet B (UVB) light to stimulate the body's natural production of vitamin D, promoting the synthesis of essential hormones and peptides critical for overall health and well-being. By offering the benefits of sunlight without the harmful UVA rays or the complications associated with vitamin D supplements, Solius enhances physical, mental, and immune functions. The company also developed a UV light system intended for treating COVID-19, further demonstrating its commitment to harnessing light technology for health improvements.

Lazurite

Seed Round in 2017
Lazurite is a medical device company focused on wireless imaging and lighting technologies for minimally invasive surgery. It develops modular wireless camera and lighting platforms that remove wires and enhance operating room safety and efficiency. The product family includes ArthroFree, a fully wireless minimally invasive camera system for the operating room, and ORFree, a wireless mobile surgical camera platform, both enabled by the Meridiem light engine technology. These innovations aim to simplify the surgical setup, improve visualization, and enable greater maneuverability during procedures.

M&S Biotics

Seed Round in 2017
M&S Biotics develops healthcare IoT systems that enhance surgical efficiency, safety, and outcomes by automating instrument counting and data collection in the operating room. Its Biotic Integration system uses radio frequency identification and artificial intelligence to track, count, and locate surgical items in real time, while Biotic Insight provides analytics on instrument utilization. The platform also includes a Smart Table for real-time monitoring and coordination of tools and staff across procedures, enabling hospitals to reduce procedural risks, optimize resource use, and potentially increase surgical capacity.

Myontec

Seed Round in 2017
Myontec Ltd., headquartered in Kuopio, Finland, specializes in developing, manufacturing, and marketing wearable sensory solutions designed to measure muscle activity and other bio-signals from the human body. The company's flagship product is Myontec Mbody, a pair of smart shorts equipped with real-time muscle sensing technology, accompanied by a mobile app for exercise analysis and tracking. Additionally, they offer the MyOnWear Research System for field studies and measurement services for various applications such as sports performance testing, coaching, research on occupational health, and biofeedback training.

Aerobit Health

Seed Round in 2017
Aerobit Health Ltd. is a Manchester-based company founded in 2016 that specializes in asthma management through the development of a smart inhaler and an integrated platform. The smart inhaler monitors and records usage, providing users with reminders for their prescribed medication regimen. It also enables healthcare providers to track patient treatment progress and compliance. The device assesses the quality of each dose and syncs data with the accompanying application, which can communicate with healthcare professionals via Bluetooth or SIM card. By leveraging advanced technology and big data analytics, Aerobit Health aims to alleviate the challenges associated with asthma, ultimately reducing the burden of this chronic disease on individuals and society.

Fruit Street

Series B in 2017
Fruit Street offers a virtual diabetes prevention program. It helps participants adopt healthier lifestyles to prevent type 2 diabetes through online classes, personalized tracking of diet and activity, and integration with wireless scales for progress monitoring.

SmartTab

Seed Round in 2016
SmartTab is a pharmaceutical company developing wireless drug delivery and monitoring technologies. Its platform centers on an ingestible capsule equipped with an electronic receiver and actuator to enable targeted medication delivery and real-time monitoring. The company aims to improve patient outcomes and treatment adherence through platforms such as TargetTab, InjectTab, and MultiTab, leveraging inductive power and Internet of Medical Things integration to optimize therapy. Founded in 2015 and based in Denver, Colorado, SmartTab focuses on creating low-toxicity delivery systems and data-enabled therapy management.

GCN Health

Seed Round in 2016
GCN Health

GenID Solutions

Seed Round in 2016
GenID Solutions is a healthcare technology company dedicated to preventing cancer through early detection and genetic innovation. The company has developed a platform that identifies patients at risk for hereditary cancers, allowing healthcare providers to prescribe preventive genetic treatments effectively. By focusing on genetics-focused clinical decision support, GenID Solutions offers a unique product that integrates seamlessly with existing electronic medical records (EMR) systems, requiring no additional training for users. The platform is designed to enhance patient outcomes by facilitating timely testing and intervention for those carrying cancer-related genes. Furthermore, GenID Solutions ensures compliance with HIPAA regulations, prioritizing patient privacy and data security in its mission to transform cancer care.

Qura

Venture Round in 2016
Founded in 2015, Qura develops ultra-miniature implantable devices for monitoring physiological pressure changes. These devices have the potential to transform biomedicine by enabling real-time disease monitoring and timely treatments.

Mediktor

Venture Round in 2016
Mediktor is a developer of an advanced pre-diagnosis tool that utilizes artificial intelligence and natural language recognition to facilitate accurate symptom checking, triage, and decision-making support. The system is clinically validated and aims to transform healthcare by reducing access barriers for patients. It allows individuals to make informed decisions based on their initial symptoms while enabling healthcare providers to efficiently manage demand and optimize resources. Mediktor's technology connects patients with medical professionals within health insurance networks, assisting hospitals and health systems in making safe, rapid, and cost-effective healthcare decisions.

WeaRobot

Seed Round in 2016
Wearobot is a company that specializes in the design and development of wearable robotic exoskeletons. These devices serve multiple purposes, including assisting with motion, rehabilitation, and human augmentation. Targeting elderly individuals and those with physical impairments, Wearobot's exoskeletons enhance physical stability and mobility, facilitating greater independence for users. By focusing on accessibility, the company aims to democratize the benefits of robotic assistance, making advanced mobility solutions available to a wider audience.

LS CancerDiag Oy

Seed Round in 2016
LS CancerDiag Ltd is committed to reducing cancer mortality rates with an efficient, simple diagnostic method that detects an inherited cancer-causing condition prior to cancer. Their vision is to see DiagMMR™ as a new global testing standard in LS diagnostics. Lynch syndrome is the main cause of hereditary colorectal cancers and it also causes a broad spectrum of other tumors. With a significant proportion of the world’s population carrying the Lynch syndrome mutation, there are potentially tens of millions under a severe risk for being affected by LS. Their groundbreaking DiagMMR™ assay is an easy functional test that can be used for diagnosis of MMR deficiency i.e. Lynch syndrome (previously known as Hereditary Non­Polyposis Colorectal Cancer; HNPCC). Their mission is to save lives through an innovation that dramatically simplifies diagnostics of Lynch syndrome by delivering predictive and accurate results with a fast, unique and cost-efficient method globally.

MDOPS Corporation

Venture Round in 2016
MDOps Corporation specializes in developing clinical documentation solutions tailored for the in-patient and long-term care practitioner community. Founded in 2010 and based in Melville, New York, the company offers innovative tools such as Mili, an AI-powered virtual clinical assistant that comprehends natural language commands from physicians, facilitating instant retrieval and analysis of patient data. Mili aids in suggesting optimal care plans that adhere to clinical guidelines, thereby enhancing decision-making and minimizing errors. Additionally, MDOps provides MDLog for clinical documentation and EMR systems that support clinical decision-making, quality measures, and secure messaging. By integrating artificial intelligence and workflow automation, MDOps aims to empower healthcare providers to deliver efficient and effective patient care while improving overall outcomes.

ProjectVision

Seed Round in 2016
ProjectVision's platform provides clinicians with the right insights to help patients overcome the key environmental, psychological, and social barriers that inhibit long term health behavior change and lead to health outcomes disparities. Combining behavioral data from their free health management app, biometric data from connected devices, and GPS data from the smartphone, their platform generates individualized daily challenges that are tailored to each patient's psychological readiness for change and that are sensitive to the patient's environmental limitations. They combine existing clinical research and their own behavior risk algorithms into a behavioral risk index that can consistently improve behavioral compliance across a wide range of demographic groups and managed conditions.

Flosonics Medical

Venture Round in 2016
Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

WinguMD

Venture Round in 2016
WinguMD, Inc., founded in 2013 and based in Palo Alto, California, is a privately held company specializing in mobile clinical communications and telehealth solutions. The company was established by Oliver Aalami, MD, and Manabu Tokunaga with the aim of enhancing care delivery workflows for physicians, suppliers, payers, and patients. WinguMD offers the ZenSnap® platform, which enables medical professionals to capture and share images for diagnostic purposes while ensuring security and compliance. The platform incorporates metadata collection and tagging tools, allowing for efficient and safe medical image analysis and collaboration.

Cohero Health

Seed Round in 2015
Cohero Health, Inc. is a digital respiratory health company that focuses on developing solutions for the management of asthma and chronic obstructive pulmonary disease. The firm offers a connected health platform that includes the BreatheSmart app, which provides personalized reminders for medication adherence, tracks inhaler usage, measures lung function, and monitors symptoms and environmental conditions. Cohero Health also supplies mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker for both control and rescue medications. Additionally, the company offers BreatheSmart Connect, a Software-as-a-Service solution that facilitates remote monitoring and communication between patients and healthcare providers. Founded in 2012 and headquartered in New York, Cohero Health operates as a subsidiary of AptarGroup, Inc.

CNS Therapy

Seed Round in 2015
CNS Therapy is a spin-off from the University of North Carolina that develops mind-body therapy-based solutions and devices to alleviate chronic pain and related conditions. It combines operant behavioral therapy with a proprietary device called SET, Systolic Extinction Training, to enhance learning and reset the autonomic nervous system, with the aim of delivering long-lasting pain relief. The company tracks physiological parameters and uses the resulting data to optimize therapy, delivering an integrated program of psychological training and electrostimulation to help patients reduce or eliminate pain and return to daily activities.

MedXCom

Seed Round in 2015
MedXCom is a hybrid medical answering service that has transformed the live operator answering service industry by integrating advanced technology with traditional practices. Originally designed to protect doctors from nuisance lawsuits, it offers a sophisticated platform that intelligently screens calls, directing only urgent matters to on-call providers while filtering out non-urgent requests such as prescription refills and appointment changes. The company's system enhances communication between doctors and patients by seamlessly integrating with various medical systems, including scheduling, billing, electronic prescriptions, secure messaging, and electronic medical records. This approach not only improves the efficiency of medical practices but also supports initiatives like Patient Centered Medical Homes and Meaningful Use, ensuring that patient care remains the primary focus. MedXCom’s innovative solutions represent a significant advancement in healthcare communication and operational workflow.

Stethos

Seed Round in 2015
Stethos is a company that specializes in the design and development of high-quality electronic stethoscopes. Its innovative product is engineered to capture minute responses from the lungs and heart, providing healthcare providers with advanced tools for monitoring, recording, and replaying vital sounds. By enhancing the diagnostic process, Stethos aims to improve the accuracy and efficiency of patient assessments in clinical settings.

Breathresearch

Seed Round in 2015
BreathResearch, Inc., based in Walnut Creek, California, specializes in developing portable spirometers and applications for tracking and early detection of respiratory ailments. Founded in 2008, the company focuses on converting the air waves from breathing into sound waves, which allows for advanced respiratory analytics aimed at improving health, fitness, and performance. BreathResearch is also working on new wearable technology to simplify and make affordable cardiorespiratory assessments accessible to both athletes and patients at risk for heart or lung diseases. Its flagship device, Breath Acoustic, leverages breath analysis to detect lung and heart conditions, providing valuable tools for lifestyle consumers and individuals with chronic health issues to monitor their cardiorespiratory fitness and facilitate early detection of potential health complications.

Healthtour

Seed Round in 2015
Healthtour is a health tourism platform designed to facilitate access to medical care for patients seeking treatment abroad. It serves as an international hub, providing comprehensive information about health centers, clinics, and medical services worldwide. Users can compare hospitals based on services, treatments, and costs, allowing them to make informed decisions about their healthcare options. In addition to facilitating the selection of medical providers, Healthtour also offers support for essential logistical aspects, including transportation and accommodation for patients traveling for health-related purposes. Through its services, Healthtour aims to enhance the medical tourism experience by streamlining access to quality care across different locations.

Skindroid

Venture Round in 2015
Skindroid, founded in 2014 by Winston Capel and Somair Riaz, is a Colorado-based company that specializes in the manufacturing and distribution of innovative skin biosensors for wearable devices. The company focuses on developing intelligent sensors that enable non-invasive monitoring of skin-based sweat through IoT technology. Skindroid's devices analyze molecules in sweat, providing automatic biometric readouts via a mobile application. This functionality allows users to optimize their workouts and prevent injuries by gaining deeper insights into their physiological data.

BioClaim

Seed Round in 2015
BioClaim is a developer of a patented biometric software platform that enhances patient authentication in healthcare settings, aiming to eliminate healthcare fraud and protect patient privacy. The system employs biometric devices, primarily fingerprint scanners, which replace traditional sign-in methods at physicians' offices. When patients enter a facility, they sign in by placing their finger on the scanner, which converts the biometric information into a secure template without storing the actual print, thereby maintaining compliance with privacy regulations. The software can also integrate with various electronic health record (EHR) systems to ensure accurate patient identification, linking service entries to the correct individuals to prevent medical identity theft. BioClaim offers flexibility by supporting multiple hardware platforms and operating systems, allowing clients the choice of installation in various network environments. The platform has been continuously developed since 2003, adhering to industry standards and evolving to meet client needs in a rapidly changing technological landscape.

Clariflow

Seed Round in 2014
ClariFlow is a clinically proven and patented DIY device for men to identify early signs of BPH. Urologists also get patient referrals through their mobile app. ClariFlow is the first home test for BPH. Developed over 10 years by researchers in Europe and clinically tested around the world including UCLA, ClariFlow lets you test for maximum urinary flow rate, which is one of the indicators of BPH. Simply preorder the kit online here. It’ll get shipped to you in a discreet package. In conjunction with your symptoms checklist, the easy-to-read gauge will tell you if you’re at risk for BPH. BPH is short for Benign Prostatic Hyperplasia. It means that your prostate is enlarged and this may cause problems with you ability to urinate. For example, you may feel that you’re urinating more frequently than before or that you’re unable to urinate completely. Perhaps your urination interferes with your ability to sleep through the night or you’re getting more urinary tract infections. These are all potential signs that you may have BPH. BPH is very common. Half of men over 50 years old experience this condition, as do 75% of men over 80. Even men in their 30s can begin to experience the symptoms, so you or your loved one is far from being alone. Early diagnosis of BPH is really important. Once you and your doctor know that you have BPH, there are medications that you can take to reduce the need for frequent urination and the uncomfortable feelings associated with BPH. Finding out early also reduces the chances that you’ll need surgery later on to correct for your symptoms. And lastly, it’s always a good idea to rule out more serious conditions, such as prostate cancer, as soon as you can, because they sometimes present similar symptoms. BPH can be easily treated if diagnosed early. If left untreated, it can lead to urinary tract infections, incontinence, urinary retention, and other unpleasant symptoms. Extreme cases may call for the use of a catheter in order to empty the bladder, or even surgical intervention.

LifeBio

Venture Round in 2014
LifeBio is an agetech company that enables individuals and care teams to capture, preserve, and share life stories to support health and person-centered Alzheimer's care. Its platform includes LifeBio Memory, a solution for people living with dementia and their care partners to document biographical history, and MyHello, a loneliness intervention accessible by phone. The service is deployed by healthcare and senior living providers as a compliant storage cloud for biographies and life stories, featuring online templates of biography and autobiography questions designed to elicit meaningful life details and experiences, to inform care planning and enhance well-being as aging and memory loss occur.

Accel Diagnostics

Seed Round in 2014
Accel Diagnostics, LLC is a medical diagnostics company based in Pittsburgh, Pennsylvania, founded in 2008. The company develops innovative diagnostic technologies, including the pScreen Card, a disposable, credit-card-sized blood diagnostic platform that detects and quantifies biomarkers through a companion mobile application. This lab-on-chip technology allows for rapid diagnosis of infectious and chronic diseases at the point-of-care, delivering accurate results within 30 minutes and enhancing the quality of care while reducing costs. Additionally, Accel Diagnostics focuses on heart failure management, enabling patients to monitor their condition at home and allowing timely responses to heart distress before severe symptoms arise. This approach aims to reduce life-threatening events and prevent costly hospitalizations, representing a significant advancement in patient care for congestive heart failure.

Althea Health

Seed Round in 2014
Althea Health is a San Francisco-based healthcare startup focused on addressing rare and neglected diseases through a digital platform that integrates smartphones, connected health devices, electronic medical record (EMR) data, and user-generated information. Founded out of a personal experience with a complex, undiagnosed condition, Althea Health aims to empower communities facing intricate health challenges by providing tools for collective health insights. The platform facilitates collaboration among patients, researchers, and pharmaceutical companies, enhancing the ability to capture and analyze health data. Through this engagement, Althea Health seeks to accelerate the discovery of new treatments and improve standards of care, ultimately enhancing life expectancy and quality for individuals with rare diseases.

PHmHealth

Seed Round in 2014
PHmHealth LLC is a Philadelphia-based company that specializes in mobile healthcare technology, founded in 2012. The company has developed a smartphone application that leverages Near Field Communication technology alongside patent-pending geo-locational fingerprinting to enhance efficiency and reliability in the home healthcare sector. This platform enables healthcare providers to verify visits, track interactions, and upload data to a secure cloud-based server. By improving accountability in healthcare settings, PHmHealth empowers home healthcare agencies, long-term care facilities, hospitals, pharmaceutical delivery services, healthcare payers, and families to monitor visit information and service duration, ultimately facilitating better healthcare delivery.

Health 123

Seed Round in 2014
Health 123, Inc. operates health123.com, an online platform designed to help individuals enhance their health through personalized guidance. Founded in 2011 and based in Seattle, Washington, the company offers tools that enable users to track and understand key health metrics, including weight management, heart health, nutritional balance, energy levels, and emotional wellness. In addition to these resources, Health 123 sells a variety of products online, including supplements, blood test kits, books, scales, and health tracking devices. The company also provides a Health Activation Platform that fosters patient engagement by delivering curated content, personalized care plans, and direct communication with healthcare teams. This platform is designed to improve health literacy and empower users, ultimately leading to better health outcomes and increased patient satisfaction. As of January 2017, Health 123 operates as a subsidiary of Samepage Inc.

Tickit Health

Seed Round in 2013
Tickit Health develops a patient engagement platform focused on mental health screening and navigation. Its interactive questionnaires enable healthcare organizations worldwide to identify at-risk patients efficiently, improving outcomes across the care continuum.

Cohero Health

Seed Round in 2013
Cohero Health, Inc. is a digital respiratory health company that focuses on developing solutions for the management of asthma and chronic obstructive pulmonary disease. The firm offers a connected health platform that includes the BreatheSmart app, which provides personalized reminders for medication adherence, tracks inhaler usage, measures lung function, and monitors symptoms and environmental conditions. Cohero Health also supplies mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker for both control and rescue medications. Additionally, the company offers BreatheSmart Connect, a Software-as-a-Service solution that facilitates remote monitoring and communication between patients and healthcare providers. Founded in 2012 and headquartered in New York, Cohero Health operates as a subsidiary of AptarGroup, Inc.

Respondwell

Seed Round in 2013
RespondWell, LLC is a digital health company that specializes in telerehabilitation technology. Founded in 2003 and based in Grand Rapids, Michigan, the company offers a comprehensive platform designed for patients, outpatient rehabilitation clinics, hospital systems, and senior care facilities. RespondWell provides a range of modules, including prevention and rehabilitation, as well as clinical content and clinician tools, facilitating patient assessment, engagement, and reporting. The platform supports total joint replacement patients by enabling healthcare providers to connect and monitor patients while collecting valuable data. Patients can access instructional videos for physical therapy conducted by virtual instructors, enhancing their rehabilitation experience. RespondWell also features engagement incentives through in-product rewards and offers two specific online programs, Therapy@Home and Fitness@Home. The company became a subsidiary of Zimmer Biomet Signature Solutions in October 2016.

Medicast

Venture Round in 2013
Medicast is a technology platform designed to assist hospitals and healthcare systems in delivering personalized care directly to patients in their homes. Founded on the principle that health begins at home, Medicast connects patients with physicians to facilitate on-demand healthcare services, including scheduling in-person house calls and virtual visits. The platform is recognized as the only mobile-first logistics and management solution for such care delivery, developed through collaboration with both patients and healthcare providers. Medicast's user-friendly technology enhances provider efficiency and utilization while improving satisfaction for both patients and providers.

Gene By Gene

Seed Round in 2013
Gene By Gene, Ltd., founded in 2000 and headquartered in Houston, specializes in comprehensive DNA testing services for both consumer and institutional clients. The company operates through four divisions: Family Tree DNA, which was a pioneer in direct-to-consumer genetic genealogy testing; DNA Traits, its clinical-health division that provides regulated diagnostic tests; DNA DTC, focusing on research use only services; and DNA Findings, which offers AABB certified paternity testing. Gene By Gene is CLIA registered and maintains a state-of-the-art Genomics Research Center, allowing it to facilitate genomic studies and make next-generation DNA sequencing and clinical genomics accessible and affordable for medical researchers worldwide.

AdhereTech

Venture Round in 2013
AdhereTech Inc. is a New York-based company that specializes in developing smart pill bottles designed to improve medication adherence for patients on specialty medications. Founded in 2011, AdhereTech's innovative technology tracks the contents of its pill bottles, determining when doses are missed, and wirelessly uploads this data to a secure server. The system sends timely reminders to patients who have missed their medication, thereby enhancing their adherence to prescribed therapies. AdhereTech serves a diverse clientele that includes major pharmaceutical manufacturers and top specialty pharmacies, and its clinically-proven results have been published in leading peer-reviewed journals. By helping patients maintain consistent medication regimens, AdhereTech ultimately supports improved health outcomes and ensures that patients remain on life-saving therapies for longer periods.

Babyscripts

Seed Round in 2013
Babyscripts is a health technology company that provides a virtual maternity care platform for prenatal and postpartum management. The platform combines a mobile education layer with gestational-age content and resources through one year postpartum, remote monitoring using connected medical devices, and a collaboration with payers to improve care coordination and reduce costs. This three-tier approach enables clinicians to manage pregnancies outside the clinic, monitor risk factors remotely, and intervene promptly when needed, while expanding access and automating routine elements of care to support better outcomes for mothers and infants.

Oxitone Medical

Venture Round in 2013
Oxitone Medical is a medical device company that has developed a wrist-based pulse oximetry continuous monitoring platform for home care and remote patient management. The FDA-cleared solution uses AI-assisted analytics to turn continuous data into personalized therapeutic guidance without requiring a fingertip probe, enabling efficient remote monitoring of high-risk patients. The system is deployed in more than ten countries and supports continuous data collection for hyper-personalized interventions, with partnerships including Ascom for monitoring COVID-19 patients.

ItMD

Seed Round in 2013
ItMD is a Florida-based company founded in 2010 by Halland Chen. It specializes in a cloud-based platform for sharing medical images securely among healthcare providers and patients. The platform offers features such as institutional sharing, PACS and RIS integration, collaborative medicine, study sharing, CD elimination, image control, and robust security measures. This enables institutions to efficiently manage and share studies, doctors to collaborate on cases, and patients to access and control their medical images securely online.

Beyond Lucid Technologies

Venture Round in 2012
Beyond Lucid Technologies, Inc. is a cloud-based software company specializing in the emergency medical, disaster management, and first response sectors. Founded in 2009 and headquartered in Concord, California, the company offers innovative solutions designed to enhance the safety, efficiency, and cost-effectiveness of Fire, Ground, and Air Emergency Medical Services. Its flagship product, MEDIVIEW Mobile, serves as a healthcare IT platform that connects first responders with hospitals, facilitating situational awareness and logistical decision support during patient transport. Additionally, Beyond Lucid Technologies provides MEDIVIEW Hub, a prehospital health information exchange, and MEDIVIEW Trips, which focuses on community paramedicine, non-emergency medical transportation dispatch, and scheduling. The company has established connections with over 115 hospitals across 27 U.S. states and Australia, earning recognition for its contributions to emergency medical technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.